125 related articles for article (PubMed ID: 38788311)
1. How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic.
Hawranek C; Rosén A; Hajdarevic S
Patient Educ Couns; 2024 Sep; 126():108319. PubMed ID: 38788311
[TBL] [Abstract][Full Text] [Related]
2. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
4. The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer.
Öfverholm A; Karlsson P; Rosén A
Eur J Hum Genet; 2024 May; 32(5):539-544. PubMed ID: 38355958
[TBL] [Abstract][Full Text] [Related]
5. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
Trials; 2014 Mar; 15():86. PubMed ID: 24649895
[TBL] [Abstract][Full Text] [Related]
6. Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives.
Hayat Roshanai A; Lampic C; Rosenquist R; Nordin K
Fam Cancer; 2010 Dec; 9(4):669-79. PubMed ID: 20577820
[TBL] [Abstract][Full Text] [Related]
7. Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.
Bednar EM; Rauh-Hain JA; Garcia JJ; de Aguinaga N; Powell MA; Peral SL; Nitecki R; Jorgensen K; Rudy NL; Lu KH; Leath CA; Scarinci IC
Cancer Prev Res (Phila); 2024 Jan; 17(1):19-28. PubMed ID: 37913800
[TBL] [Abstract][Full Text] [Related]
8. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
[TBL] [Abstract][Full Text] [Related]
9. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
Roshanai AH; Rosenquist R; Lampic C; Nordin K
Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
[TBL] [Abstract][Full Text] [Related]
10. Genetic Test Results and Disclosure to Family Members: Qualitative Interviews of Healthcare Professionals' Perceptions of Ethical and Professional Issues in France.
D' Audiffret Van Haecke D; de Montgolfier S
J Genet Couns; 2016 Jun; 25(3):483-94. PubMed ID: 26482743
[TBL] [Abstract][Full Text] [Related]
11. A Relational Approach to Genetic Counseling for Hereditary Breast and Ovarian Cancer.
Forbes Shepherd R; Browne TK; Warwick L
J Genet Couns; 2017 Apr; 26(2):283-299. PubMed ID: 27761849
[TBL] [Abstract][Full Text] [Related]
12. "I have always lived with the disease in the family": family adaptation to hereditary cancer-risk.
Silva E; Gomes P; Matos PM; Silva ER; Silva J; Brandão C; Castro F; Neves MC; Sales CMD
BMC Prim Care; 2022 Apr; 23(1):93. PubMed ID: 35461227
[TBL] [Abstract][Full Text] [Related]
13. Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics.
Derbez B; de Pauw A; Stoppa-Lyonnet D; de Montgolfier S
Fam Cancer; 2017 Jul; 16(3):447-457. PubMed ID: 28293859
[TBL] [Abstract][Full Text] [Related]
14. Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.
Sharff ME; DeMarco TA; Mays D; Peshkin BN; Valdimarsdottir HB; Garber JE; Schneider KA; Patenaude AF; Tercyak KP
Genet Test Mol Biomarkers; 2012 May; 16(5):376-82. PubMed ID: 22085394
[TBL] [Abstract][Full Text] [Related]
15. Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives.
Hamilton JG; Peshkin BN; Mays D; DeMarco TA; Patenaude AF; Tercyak KP
Psychooncology; 2018 Jul; 27(7):1825-1832. PubMed ID: 29645321
[TBL] [Abstract][Full Text] [Related]
16. Is there a "right time" for bad news? Kairos in familial communication on hereditary breast and ovarian cancer risk.
Derbez B
Soc Sci Med; 2018 Apr; 202():13-19. PubMed ID: 29500986
[TBL] [Abstract][Full Text] [Related]
17. Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.
Gilbar R; Shalev S; Spiegel R; Pras E; Berkenstadt M; Sagi M; Ben-Yehuda A; Mor P; Perry S; Zaccai TF; Borochowitz Z; Barnoy S
J Genet Couns; 2016 Apr; 25(2):314-24. PubMed ID: 26371363
[TBL] [Abstract][Full Text] [Related]
18. Motivation and family communication in hereditary prostate cancer genetic testing: Survey of patients from a US tertiary medical center.
Finn CM; McCormick S; Peterson D; Niendorf KB; Rodgers LH
J Genet Couns; 2023 Feb; 32(1):79-89. PubMed ID: 35941805
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.
Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY
J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632
[TBL] [Abstract][Full Text] [Related]
20. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.
van den Heuvel LM; Smets EMA; van Tintelen JP; Christiaans I
J Genet Couns; 2019 Oct; 28(5):1042-1058. PubMed ID: 31216099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
